Latest News
2011-12-08
Site Raubling successfully inspected by FDA
PharmaZell GmbH is pleased to announce that its manufacturing site at Raubling, Germany, has successfully passed a FDA inspection in the week of December 5th, 2011 without any FDA form 483 observation. This inspection outcome reconfirms the GMP compliance of Raubling site of last FDA inspection in 2007.
2011-11-24 Joint development agreement with German university
Pharmazell has entered into a joint development agreement with a reputable university in Germany in the field of biocatalysis. Under this 3 years' cooperation agreement specific technologic reactions like stereoselective reductions will be investigated and optimized. The results will be commercialized by Pharmazell exclusively.
2011-11-10 Site Chennai successfully inspected by FDA
PharmaZell (India) Private Ltd.is pleased to announce that it has successfully passed an FDA inspection which has been performed at its Chennai site in the week of November 7th, 2011 without any FDA form 483 observation. This inspection was the second FDA inspection of the site following the first successful FDA inspection in 2008.
Events
Meet us at the following conferences:
DCAT, New York, March 12 - 15th, 2012
CPHI worldwide, Madrid, October 9th - 11th, 2012, booth no. follows
2010 - charity activities by plant Vizag